Davos Mechanisms of ACS: the clinical perspective. Filippo Crea Institute of Cardiology Catholic University of the Sacred Heart Rome, Italy

Size: px
Start display at page:

Download "Davos Mechanisms of ACS: the clinical perspective. Filippo Crea Institute of Cardiology Catholic University of the Sacred Heart Rome, Italy"

Transcription

1 Davos 2015 Mechanisms of ACS: the clinical perspective Filippo Crea Institute of Cardiology Catholic University of the Sacred Heart Rome, Italy

2 No conflict of interest to declare

3 Why? C-reactive protein Berk et al, AJC 1990 Liuzzo et al, NEJM 1994 Neutrophils Dinerman et al, JACC 1990 Biassucci et al, JACC 1994 Monocytes Mazzone et al, Circulation 1993 Lymphocytes Serneri et al, Circulation 1992

4 Dysregulation of T cell subsets in ACS (Liuzzo et al, IJC 2013)

5 CD31 signaling in immunomodulation CREB Treg (Flego et al, Basic Res Cardiol 2014)

6 Auto-antigens Obstructive ATS with adaptive immunity activation Plaque fissure White/red thrombus Infectious agents

7 Association between inflammation and CV events CRP < 2mg/dl in 41% of patients! (Cianflone et al, JACC 2012)

8 Cluster analysis according to T cell subsets and their ratio 100% 80% Cluster analysis 60% 40% 20% 0% CD4 + CD28 null T-cells > 4% Tregs < 5% Ratio > 2 ACS SA Controls Present (Liuzzo et al, IJC 2013)

9

10 Mechanical triggers of plaque fissure: stress Mechanisms of stress-induced ACS associated Hypertension Plaque fissure rate (%) to plaque fissure Constriction of epicardial coronary arteries Increase of coronary microvascular resistance Platelet activation and hypercoagulability Stress (Burke et al, JAMA 1999) Rest

11 Mechanical triggers of plaque fissure: cholesterol crystals Factors affecting cholesterol crystallization Cholesterol saturation Hydration Temperature ph (Abela et al, Clin Cardiol 2005, AJC 2009)

12 Auto-antigens Systemic stress Obstructive ATS with adaptive immunity activation Plaque fissure White/red thrombus Plaque fissure Obstructive ATS without systemic inflammation Infectious agents Local stress

13 Plaque erosion (Fog Bentzon et al, Circ Res 2014)

14 Myeloperoxidase is Associated with Coronary Plaque Erosion (Ferrante et al, Circulation 2010)

15 Differential accumulation of hyaluronan expressing CD44 in culprit lesions (Kolodgie et al, ATVB 2002)

16 Auto-antigens Systemic stress Obstructive ATS with adaptive immunity activation Plaque fissure White/red thrombus Plaque fissure Obstructive ATS without systemic inflammation Infectious agents Plaque erosion Local stress Strong local thrombogenic stimuli Obstructive ATS with innate immunity activation Neutrophil recruitment

17 Mortality of patients with NSTE-MI and nonobstructive CAD in ACUITY (n=2442; 8.8% MINOCA) (Planer et al, Circ Cardiovasc Interv 2014))

18

19 Coronary microvascular dysfunction in Tako-tsubo syndrome Contrast score index End-sistolic volume Ejection fraction (Galiuto et al, EHJ 2010) (De Caterina AR et al, EHJ 2010)

20 Vasoconstrictor stimuli No obstructive ATS Dysfunctional endothelial and/or SMC Auto-antigens Proximal or distal spasm Systemic stress Obstructive ATS with adaptive immunity activation Plaque fissure White/red thrombus Plaque fissure Obstructive ATS without systemic inflammation Infectious agents Plaque erosion Local stress Strong local thrombogenic stimuli Obstructive ATS with innate immunity activation Neutrophil recruitment

21 Plaque rupture and erosion assessed by OCT portend a different outome in ACS (n=139) (Niccoli et al, EHJ 2015)

22 Rupture Erosion Smooth plaque

23 Morpho-functional correlations in NSTE-ACS (Niccoli et al, IJC 2014)

24 Targeting the mechanisms of ACS Plaque fissure with inflammation Plaque fissure without inflammation Methotrexate, IL-1b antagonists, Treg expansion, Vaccines Colchicine Plaque erosion Antithrombotics SMC hyperreactivity Vasodilators

25 It is complex I am sorry, it is not my fault!

26 SMC function assessment No obstructive ATS Cystatin C Rho kinase Molecular imaging for T-cells Proximal or distal spasm Anatomical imaging Obstructive ATS with adaptive immunity activation Plaque fissure White/red thrombus Plaque fissure Obstructive ATS without systemic inflammation CRP T-cell perturbation Plaque erosion Markers of cholesterol crystallization Molecular imaging for MPO Obstructive ATS with innate immunity activation MPO

27 Cholesterol crystals and plaque fissure (Fog Bentzon et al, Circ Res 2014)

Women and Coronary Artery Disease:

Women and Coronary Artery Disease: Women and Coronary Artery Disease: Less is More? Interventional Cardiology 2017 32 th Annual International Symposium Snow Mass March 5-10 Yolande Appelman MD, PhD,FESC EAPCI-Women Interventional Cardiologist

More information

Coronary plaque erosion: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESC Institute of Cardiology Catholic University, Rome, Italy

Coronary plaque erosion: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESC Institute of Cardiology Catholic University, Rome, Italy Coronary plaque erosion: a clinical case, MD, PhD, FESC Institute of Cardiology Catholic University, Rome, Italy Coronary plaque erosion: a clinical case B.M. Age: 59 years Sex: female. Cardiological risk

More information

SYSTEMATIC MANUAL THROMBUS ASPIRATION: PRO

SYSTEMATIC MANUAL THROMBUS ASPIRATION: PRO SYSTEMATIC MANUAL THROMBUS ASPIRATION: PRO FRANCESCO BURZOTTA INSTITUTE OF CARDIOLOGY CATHOLIC UNIVERSITY OF THE SACRED HEART ROME, ITALY CONTROVERSIES IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION ESC

More information

INFLAMMATION AND ATHEROSCLEROSIS. Rob Greenfield MD FACC FAHA FNLA California Heart Associates University of California, Irvine

INFLAMMATION AND ATHEROSCLEROSIS. Rob Greenfield MD FACC FAHA FNLA California Heart Associates University of California, Irvine INFLAMMATION AND ATHEROSCLEROSIS Rob Greenfield MD FACC FAHA FNLA California Heart Associates University of California, Irvine What determines who will develop atherosclerosis? LDL-CHOLESTEROL?? OTHER

More information

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2

12/18/2009 Resting and Maxi Resting and Max mal Coronary Blood Flow 2 Coronary Artery Pathophysiology ACS / AMI LeRoy E. Rabbani, MD Director, Cardiac Inpatient Services Director, Cardiac Intensive Care Unit Professor of Clinical Medicine Major Determinants of Myocardial

More information

Pathogenesis of Acute Coronary Syndromes

Pathogenesis of Acute Coronary Syndromes Journal of the American College of Cardiology Vol. 61, No. 1, 2013 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.07.064

More information

FFR and outcome: The mechanistic link

FFR and outcome: The mechanistic link FFR and outcome: The mechanistic link Bernard De Bruyne Cardiovascular Center Aalst Belgium Mechanisms of Plaque Destabilization Stenosis Hemodynamics Thrombotic Occlusion Blood/ Platelets Histopathology

More information

OCT guidance for distal LM lesions

OCT guidance for distal LM lesions OCT guidance for distal LM lesions FRANCESCO BURZOTTA INSTITUTE OF CARDIOLOGY CATHOLIC UNIVERSITY OF THE SACRED HEART ROME, ITALY LM suitability for OCT At FU in stented LM Parodi G et al. Eurointervention

More information

Pathology of Coronary Artery Disease

Pathology of Coronary Artery Disease Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology

More information

Imaging Atheroma The quest for the Vulnerable Plaque

Imaging Atheroma The quest for the Vulnerable Plaque Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing

More information

Subclinical inflammation and peripheral artery disease. Luigi M Biasucci, M.D. Institute of Cardiology Catholic University Rome, ITALY

Subclinical inflammation and peripheral artery disease. Luigi M Biasucci, M.D. Institute of Cardiology Catholic University Rome, ITALY Subclinical inflammation and peripheral artery disease Luigi M Biasucci, M.D. Institute of Cardiology Catholic University Rome, ITALY ESC Congress 2010 Conflict of interest Research grants:sanofi-aventis,

More information

Pathology of the Vulnerable Plaque

Pathology of the Vulnerable Plaque Journal of the American College of Cardiology Vol. 47, No. 8 Suppl C 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.10.065

More information

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005 Pathology of Vulnerable Plaque Angioplasty Summit 25 TCT Asia Pacific, Seoul, April 28-3, 25 Renu Virmani, MD CVPath, A Research Service of the International Registry of Pathology Gaithersburg, MD Plaque

More information

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem

More information

Intervention: How and to which extent is technology helping us?

Intervention: How and to which extent is technology helping us? Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction

More information

Innate Immunity in Atherosclerosis

Innate Immunity in Atherosclerosis Innate Immunity in Atherosclerosis Peter Libby Brigham & Women s Hospital Harvard Medical School IAS Amsterdam May 26, 2015 ACS Stable demand angina Characteristics of Atherosclerotic Plaques Associated

More information

Pathophysiology of Coronary Microvascular Dysfunction

Pathophysiology of Coronary Microvascular Dysfunction Pathophysiology of Coronary Microvascular Dysfunction Cheol Woong Yu, MD, PhD Cardiology Department Division of Internal Medicine Korea University Anam Hospital. Etiologies of Chest Pain without obstructive

More information

Coronary Artery Thermography

Coronary Artery Thermography Coronary Artery Thermography The 10th Anniversary, Interventional Vascular Therapeutics Angioplasty Summit 2005 TCT Asia Pacific Christodoulos Stefanadis Professor of Cardiology Athens Medical School In

More information

Investigating senior athletes for cardiovascular disease. Antonio Pelliccia, MD

Investigating senior athletes for cardiovascular disease. Antonio Pelliccia, MD Investigating senior athletes for cardiovascular disease Antonio Pelliccia, MD www.antoniopelliccia.it Middle-aged, male marathon runner LAD LAD RC Replacement fibrosis Non-obstructive fibrous plaque

More information

Inflammation as A Target for Therapy. Focus on Residual Inflammatory Risk

Inflammation as A Target for Therapy. Focus on Residual Inflammatory Risk ESC Rome Monday August 29, 2016 Inflammation as A Target for Therapy Focus on Residual Inflammatory Risk Paul M Ridker, MD Eugene Braunwald Professor of Medicine Harvard Medical School Director, Center

More information

FastTest. You ve read the book now test yourself

FastTest. You ve read the book now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

Late stent thrombosis: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESc Institute of Cardiology Catholic University of Rome, Italy

Late stent thrombosis: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESc Institute of Cardiology Catholic University of Rome, Italy , MD, PhD, FESc Institute of Cardiology Catholic University of Rome, Italy P. T. Age: 60 years Sex: female. Cardiological risk factors: diabetes mellitus type II, dyslipidemia. Cardiological History: chest

More information

Use of Biomarkers for Detection of Acute Myocardial Infarction

Use of Biomarkers for Detection of Acute Myocardial Infarction Use of Biomarkers for Detection of Acute Myocardial Infarction Allan S. Jaffe, MD.* Consultant - Cardiology & Laboratory Medicine Professor of Medicine Chair, CCLS Division, Department of Laboratory Medicine

More information

Women and Heart Disease

Women and Heart Disease Women and Heart Disease The Very Latest in Cardiovascular Medicine and Surgery Gretchen L. Wells, MD, PhD, FACC Thomas Whayne Endowed Professor in Women s Heart Health Gill Heart Institute University of

More information

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,

More information

Ischemia and Myocardial Infarction with Non-obstructive CAD

Ischemia and Myocardial Infarction with Non-obstructive CAD Ischemia and Myocardial Infarction with Non-obstructive CAD Noel Bairey Merz MD, Janet Wei MD, Chrissandra Shufelt MD, Margo Minissian ACNP-BC, Saibal Kar MD, Bruce Samuels MD, Babak Azarbal MD, Tim Henry

More information

Who Cares About the Past?

Who Cares About the Past? Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring

More information

Inflammation: Novel Target for Cardiovascular Risk Reduction

Inflammation: Novel Target for Cardiovascular Risk Reduction Inflammation: Novel Target for Cardiovascular Risk Reduction Andrew Zalewski, M.D. Thomas Jefferson University, Philadelphia GlaxoSmithKline, Philadelphia Why inflammation? Population-based studies: low

More information

To follow the presentations of this congress, click on the link below:

To follow the presentations of this congress, click on the link below: International Symposium on ISCHEMIC HEART DISEASE: THE MAIN CAUSE OF MORBIDITY AND MORTALITY WORLDWIDE. WHAT CAN WE IMPROVE? Rome (IT), July 05-07, 2017 Highlights Introduction Prof. Crea, chairman of

More information

Hans Strijdom SA Heart Meeting November 2017

Hans Strijdom SA Heart Meeting November 2017 Hans Strijdom SA Heart Meeting November 2017 HIV-infection and ART, but not high sensitivity CRP, are associated with markers of vascular function: Results from the Western Cape cohort of the EndoAfrica

More information

Microvascular Disease: How to Diagnose and What s its Treatment

Microvascular Disease: How to Diagnose and What s its Treatment Microvascular Disease: How to Diagnose and What s its Treatment Laxmi S. Mehta, MD, FACC The Ohio State University Medical Center Assistant Professor of Clinical Internal Medicine Clinical Director of

More information

Can IVUS Define Plaque Features that Impact Patient Care?

Can IVUS Define Plaque Features that Impact Patient Care? Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center

More information

Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications

Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications 12 th Annual Cardiovascular Disease Prevention Symposium February 8, 2013 KEYNOTE ADDRESS Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications Ira Tabas, M.D., Ph.D. Richard J.

More information

MECHANISMS OF MYOCARDIAL ISCHEMIA

MECHANISMS OF MYOCARDIAL ISCHEMIA Página 1 de 9 MECHANISMS OF MYOCARDIAL ISCHEMIA Part of "46 - Coronary Blood Flow and Myocardial Ischemia" Myocardial ischemia develops when coronary blood flow becomes inadequate to meet the requirements

More information

actually rupture! Challenges to the vulnerable plaque concept

actually rupture! Challenges to the vulnerable plaque concept An Update on the Pathogenesis of the Acute Coronary Syndromes Peter Libby Brigham & Women s Hospital Harvard Medical School ADVANCES IN HEART DISEASE University of California San Francisco December 20,

More information

Perspective of LM stenting with Current registry and Randomized Clinical Data

Perspective of LM stenting with Current registry and Randomized Clinical Data Asian Pacific TCT Perspective of LM stenting with Current registry and Randomized Clinical Data Patrick W. Serruys MD PhD Yoshinobu Onuma MD Seung-Jung Park MD, PhD 14:48-15:00, 2009 Symposium Arena, Level

More information

63 yo woman with chest pain

63 yo woman with chest pain 63 yo woman with chest pain Coronary Microvascular Disease: Does It Exist? EA Amsterdam, MD Distinguished Professor Cardiology and Internal Medicine UC Davis School of Medicine and Medical Center Sacramento,

More information

Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress test results

Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress test results Department of Cardiovascular Medicine Università Cattolica del Sacro Cuore Rome, Italy Coronary microvascular dysfunction after elective percutaneous coronary intervention: correlation with exercise stress

More information

Best Lipid Treatments

Best Lipid Treatments Best Lipid Treatments Pam R. Taub MD, FACC Director of Step Family Cardiac Rehabilitation and Wellness Center Associate Professor of Medicine UC San Diego Health System Overview of Talk Review of pathogenesis

More information

Ischemic Heart Disease in Women

Ischemic Heart Disease in Women Ischemic Heart Disease in Women Lawrence J. Hergott, M.D. Professor of Medicine Director of Outpatient Clinical Services University of Colorado Denver Historical Perspective Regarding IHD In Women Method:

More information

USING NON -TRADITIONAL RISK MARKERS IN ASSESSING CV RISK

USING NON -TRADITIONAL RISK MARKERS IN ASSESSING CV RISK USING NON -TRADITIONAL RISK MARKERS IN ASSESSING CV RISK JAMES M FALKO MD PROFESSOR OF MEDICINE UNIVERSITY OF COLORADO Adapted from: Rader D. N Engl J Med. 2000 hs-crp (mg/l) 6 5 4 3 2 1 *p

More information

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines

Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Evidence-Based Management of CAD: Last Decade Trials and Updated Guidelines Enrico Ferrari, MD Cardiac Surgery Unit Cardiocentro Ticino Foundation Lugano, Switzerland Conflict of Interests No conflict

More information

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber

ATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber ATHEROSCLEROSIS زيد ثامر جابر Zaid. Th. Jaber Objectives 1- Review the normal histological features of blood vessels walls. 2-define the atherosclerosis. 3- display the risk factors of atherosclerosis.

More information

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece Konstantinos Toutouzas, Maria Riga, Antonios Karanasos, Eleftherios Tsiamis, Andreas Synetos, Maria Drakopoulou, Chrysoula Patsa, Georgia Triantafyllou, Aris Androulakis, Christodoulos Stefanadis 1st Department

More information

Women s Heart Health: Holistic Approaches Throughout the Lifetime - Key Differences in Heart Failure in Women

Women s Heart Health: Holistic Approaches Throughout the Lifetime - Key Differences in Heart Failure in Women Women s Heart Health: Holistic Approaches Throughout the Lifetime - Key Differences in Heart Failure in Women C. Noel Bairey Merz MD Medical Director and Barbra Streisand Women s Heart Center Preventive

More information

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis

More information

The Vulnerable Plaque

The Vulnerable Plaque 2014 The Vulnerable Plaque Volume 19. Number 1 The Vulnerable Plaque Editorial The vulnerable plaque: dealing with a looming landslide - R. Ferrari, K. Fox, F. Crea, G. Liuzzo 3 Lead Article The vulnerable

More information

FRACTIONAL FLOW RESERVE Step-by-step measurement, Practical tips & Pitfalls

FRACTIONAL FLOW RESERVE Step-by-step measurement, Practical tips & Pitfalls FRACTIONAL FLOW RESERVE Step-by-step measurement, Practical tips & Pitfalls Ahmed M ElGuindy, MSc, MRCP(UK) Division of Cardiology Aswan Heart Centre 2013 Fractional Flow Reserve Essential diagnostic tool

More information

CARDIOLOGY GRAND ROUNDS

CARDIOLOGY GRAND ROUNDS CARDIOLOGY GRAND ROUNDS Title: Acute Coronary Artery Failure Speaker: Alex R. Campbell, MD Cardiologist Minneapolis Heart Institute at Abbott Northwestern Hospital Scott W. Sharkey, MD, FACC Cardiologist

More information

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images)

Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images) Fractional Flow Reserve from Coronary CT Angiography (and some neat CT images) Victor Cheng, M.D. Director, Cardiovascular CT Oklahoma Heart Institute 1 Disclosures Tornadoes scare me 2 Treating CAD Fixing

More information

Stent Thrombosis in Bifurcation Stenting

Stent Thrombosis in Bifurcation Stenting Summit TCT Asia Pacific 2009 Stent Thrombosis in Bifurcation Stenting Associate Professor Tan Huay Cheem MBBS, M Med(Int Med), MRCP, FRCP(UK), FAMS, FACC, FSCAI Director, National University Heart Centre,

More information

Takotsubo cardiomyopathy. Joseph L. Blackshear, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Florida

Takotsubo cardiomyopathy. Joseph L. Blackshear, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Florida Takotsubo cardiomyopathy Joseph L. Blackshear, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Florida 79 year old woman, pre chemo echo for esophageal cancer Post chemo, dehydration,

More information

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical

More information

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center

Diabetes and Heart Disease. Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center Diabetes and Heart Disease Sarah Alexander, MD, FACC Assistant Professor of Medicine Rush University Medical Center No conflicts of interest or financial relationships to disclose. 2 What s the problem??

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright 22 by the Massachusetts Medical Society VOLUME 347 J ULY 4, 22 NUMBER 1 WIDESPREAD CORONARY INFLAMMATION IN UNSTABLE ANGINA ANTONINO BUFFON, M.D., LUIGI M.

More information

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT

More information

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,

More information

Diabetes and the Heart

Diabetes and the Heart Diabetes and the Heart Association of Specialty Professors April 4, 2013 Jorge Plutzky, MD Co-Director, Preventive Cardiology Director, The Lipid Clinic Cardiovascular Division Brigham and Women s Hospital

More information

LXIV: DRUGS: 4. RAS BLOCKADE

LXIV: DRUGS: 4. RAS BLOCKADE LXIV: DRUGS: 4. RAS BLOCKADE ACE Inhibitors Components of RAS Actions of Angiotensin i II Indications for ACEIs Contraindications RAS blockade in hypertension RAS blockade in CAD RAS blockade in HF Limitations

More information

Dyslipedemia New Guidelines

Dyslipedemia New Guidelines Dyslipedemia New Guidelines New ACC/AHA Prevention Guidelines on Blood Cholesterol November 12, 2013 Mohammed M Abd El Ghany Professor of Cardiology Cairo Universlty 1 1 0 Cholesterol Management Pharmacotherapy

More information

Noninvasive Fractional Flow Reserve from Coronary CT Angiography

Noninvasive Fractional Flow Reserve from Coronary CT Angiography 2016 KSC Annual Spring Scientific Conference Noninvasive Fractional Flow Reserve from Coronary CT Angiography Bon-Kwon Koo, MD, PhD, Seoul, Korea Why the hemodynamics for coronary artery disease? Twinlifemarketing.com.au

More information

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease

Inflammation and and Heart Heart Disease in Women Inflammation and Heart Disease Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular

More information

Figure 13-1: Antiplatelet Action of Aspirin (Modified After Taneja et.al 2004) ASPIRIN RESISTANCE

Figure 13-1: Antiplatelet Action of Aspirin (Modified After Taneja et.al 2004) ASPIRIN RESISTANCE CHAPTER 13 ASPIRIN Action Aspirin Resistance Aspirin Dose Therapeutic Efficacy - Secondary prevention - Acute coronary syndromes - Primary prevention Limitations and Side Effects Aspirin Aspirin should

More information

Disclosures. May 15 th, Influenza Vaccination as Secondary Prevention for Acute Coronary Events Where do we need to go in clinical practice?

Disclosures. May 15 th, Influenza Vaccination as Secondary Prevention for Acute Coronary Events Where do we need to go in clinical practice? Influenza Vaccination as Secondary Prevention for Acute Coronary Events Where do we need to go in clinical practice? May 15 th, 2014 Robi Goswami, MD Cardiologist Piedmont Heart Institute Disclosures None

More information

Non-invasive Plaque Imaging

Non-invasive Plaque Imaging Characterization of Coronary Atherosclerotic Plaques Using CTA Koen Nieman, MD Erasmus University Medical Center Thoraxcenter, dept. of Cardiology Dept. of Radiology Rotterdam, The Netherlands Massachusetts

More information

The Clinical Unmet need in the patient with Diabetes and ACS

The Clinical Unmet need in the patient with Diabetes and ACS The Clinical Unmet need in the patient with Diabetes and ACS Professor Kausik Ray (UK) BSc(hons), MBChB, MD, MPhil, FRCP (lon), FRCP (ed), FACC, FESC, FAHA Diabetes is a global public health challenge

More information

Heart Disease in Women: Diagnostic Approaches and Management

Heart Disease in Women: Diagnostic Approaches and Management Heart Disease in Women: Diagnostic Approaches and Management Ezra A. Amsterdam MD Professor, Internal Medicine Associate Chief (Academic Affairs) Chair, Writing Group of ACC/AHA UA/NSTEMI Guidelines Cardiovascular

More information

FFR? FFR-CT? Ischaemia testing?

FFR? FFR-CT? Ischaemia testing? FFR? FFR-CT? Ischaemia testing? Marco Zimarino, MD, PhD Institute of Cardiology - University G. d Annunzio, Chieti (Italy) Diagnostic management of patients with suspected stable CAD Risk stratification

More information

Mechanisms of Action for Arsenic in Cardiovascular Toxicity and Implications for Risk Assessment

Mechanisms of Action for Arsenic in Cardiovascular Toxicity and Implications for Risk Assessment Mechanisms of Action for Arsenic in Cardiovascular Toxicity and Implications for Risk Assessment Mandeep Sidhu, MD, MBA, FACC Assistant Professor of Medicine Division of Cardiology Albany Medical College

More information

Post-Procedural Myocardial Injury or Infarction

Post-Procedural Myocardial Injury or Infarction Post-Procedural Myocardial Injury or Infarction Hugo A Katus MD & Evangelos Giannitsis MD Abteilung Innere Medizin III Kardiologie, Angiologie, Pulmologie Universitätsklinikum Heidelberg Conflict of Interest:

More information

Management of Coronary Artery Spasm

Management of Coronary Artery Spasm Management of Coronary Artery Spasm J. C. Kaski and R. Arroyo-Espliguero Cardiovascular Biology Research Centre Division of Cardiac and Vascular Sciences St George s, University of London Prinzmetal s

More information

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy

The best from Euro-Echo Ischemic heart disease. Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy The best from Euro-Echo 2011 Ischemic heart disease Fausto Rigo,FESC Department of Cardiology Mestre-Venezia Hospital,Italy faustorigo@alice.it DECLARATION OF CONFLICT OF INTEREST No conflict of interest

More information

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool Vulnerable Plaque features on coronary CT Jin Ho Choi, MD, PhD Department of Internal Medicine, Emergency Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea IPS /

More information

Heart Failure with Preserved Ejection Fraction: Mechanisms and Management

Heart Failure with Preserved Ejection Fraction: Mechanisms and Management Heart Failure with Preserved Ejection Fraction: Mechanisms and Management Jay N. Cohn, M.D. Professor of Medicine Director, Rasmussen Center for Cardiovascular Disease Prevention University of Minnesota

More information

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,

More information

Focus on Acute Coronary Syndromes

Focus on Acute Coronary Syndromes Focus on Acute Coronary Syndromes Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Potential conflicts of interest Consulting fees and honoraria on my behalf go to the Cardiovascular

More information

TVA_C02.qxd 8/8/06 10:27 AM Page 19 PART 2. Pathology

TVA_C02.qxd 8/8/06 10:27 AM Page 19 PART 2. Pathology TVA_C2.qxd 8/8/6 :27 AM Page 19 2 PART 2 Pathology TVA_C2.qxd 8/8/6 :27 AM Page TVA_C2.qxd 8/8/6 :27 AM Page 21 2 CHAPTER 2 The pathology of vulnerable plaque Renu Virmani, Allen P Burke, James T Willerson,

More information

The Heart of Women s Health

The Heart of Women s Health Topics The Heart of Women s Health Molly Ware, MD Boulder Heart at Anderson Medical Center 303-532-1774 Epidemiology Mechanism of disease Screening for disease: classic and newer risk factors and tests

More information

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY Harvey D White on behalf of The STABILITY Investigators Lipoprotein- associated Phospholipase A 2 (Lp-PLA 2 ) activity:

More information

Calcified nodule as a cause of myocardial infarction with nonobstructive

Calcified nodule as a cause of myocardial infarction with nonobstructive www.edoriumjournals.com CASE REPORT PEER REVIEWED OPEN ACCESS Calcified nodule as a cause of myocardial infarction with nonobstructive coronary artery disease Kaitlyn E. Dugan, Akiko Maehara, Raymond Y.

More information

Dyslipidemia 울산의대서울아산병원심장병원심장내과이철환

Dyslipidemia 울산의대서울아산병원심장병원심장내과이철환 Dyslipidemia 울산의대서울아산병원심장병원심장내과이철환 Presentation General LDL cholesterol HDL cholesterol Future Summary A top healthcare priority 사망 / 인구 10 만 Causes of Death Worldwide, 2008 140 120 2008 년 한국인 5 대사망원인

More information

NEUTROPHIL-PLATELET INTERACTION

NEUTROPHIL-PLATELET INTERACTION NEUTROPHIL-PLATELET INTERACTION Johnny Nijm, MD; PhD Specialist in Internal medicine, Cardiology & Clinical Physiology Department of Medicine Diagnostic, Division of Clinical Physiology, County Hospital

More information

Diabete ed ASA: cosa c è di nuovo?

Diabete ed ASA: cosa c è di nuovo? Università Magna Græcia di Catanzaro Dipartimento di Medicina Sperimentale e Clinica Cattedra di Medicina Interna ed U.O. Malattie Cardiovascolari Scuola di Specializzazione in Geriatria Prof. Francesco

More information

PoS(FISBH2006)019. Imaging Vulnerable Plaque A radionuclide approach. H. William Strauss, M.D. 1

PoS(FISBH2006)019. Imaging Vulnerable Plaque A radionuclide approach. H. William Strauss, M.D. 1 A radionuclide approach H. William Strauss, M.D. 1 Section of Nuclear Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021 United States E-mail: straussh@mskcc.org Frontiers in Imaging

More information

10/17/16. Assessing cardiovascular risk through use of inflammation testing

10/17/16. Assessing cardiovascular risk through use of inflammation testing Assessing cardiovascular risk through use of inflammation testing Anthony L. Lyssy, DO Medical Director and Managing Partner Diamond Physicians Dallas, TX Response to Injury Hypothesis Injury Response

More information

Imaging congestive heart failure: role of coronary computed tomography angiography (CCTA)

Imaging congestive heart failure: role of coronary computed tomography angiography (CCTA) Imaging congestive heart failure: role of coronary computed tomography angiography (CCTA) Gianluca Pontone, MD, PhD, FESC, FSCCT Director of MR Unit Deputy Director of Cardiovascul CT Unit Clinical Cardiology

More information

Controversies in Risk Stratification

Controversies in Risk Stratification Controversies in Risk Stratification Things are not as simple as they seem Banff 2017 2015 MFMER 3494750-5 Relative importance Triggers vs Substrate in Pathophysiology of AF AF burden Paroxysmal? Persistent?

More information

FFR Fundamentals and Measurements

FFR Fundamentals and Measurements FFR Fundamentals and Measurements Ghassan S. Kassab Thomas Linnemeier Chair Professor Biomedical Engineering, Indiana University Purdue University Indianapolis Principle of FFR Q S ( P P ) / R P max d

More information

LAMIS (Livalo in AMI Study)

LAMIS (Livalo in AMI Study) JCR 2018. 12. 8 LAMIS (Livalo in AMI Study) Young Joon Hong Division of Cardiology, Chonnam National University Hospital Gwangju, Korea Trend of hypercholesterolemia in Korea < Prevalence of hypercholesterolemia

More information

Thrombectomy. how? For whom?

Thrombectomy. how? For whom? Thrombectomy how? For whom? Marco Zimarino, MD, PhD Institute of Cardiology - University G. d Annunzio, Chieti (Italy) Why Manual Thrombectomy? Pros 1 Extraction of thrombotic material, acute reduction

More information

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens Overview: 1 Definition-Pathology 2 3 Diagnostic Strategies Invasive Non Invasive Prognostic Value of Detection 4 Treatment

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction

The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction The Beneficial Role of Angiotensin- Converting Enzyme Inhibitor in Acute Myocardial Infarction Cardiovascular Center, Korea University Guro Hospital 2007. 4. 20 Seung-Woon Rha, MD, PhD Introduction 1.

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

Preventing Early Vascular Ageing (EVA) and its hemodynamic changes

Preventing Early Vascular Ageing (EVA) and its hemodynamic changes Translational Research 31 st October 2013, Moscow Preventing Early Vascular Ageing (EVA) and its hemodynamic changes Peter M Nilsson, MD, PhD Department of Clinical Sciences Lund University University

More information

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute

More information

The Gender Divide Women, Men and Heart Disease February 2017

The Gender Divide Women, Men and Heart Disease February 2017 The Gender Divide Women, Men and Heart Disease February 2017 Nandita S. Scott, MD FACC Co-Director MGH Heart Center Corrigan Women s Heart Health Program Massachusetts General Hospital Heart Disease For

More information

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016 Controversies in Coronary Revascularization Atlanta CCU April 15, 2016 Habib Samady MD FACC FSCAI Professor of Medicine Director, Interventional Cardiology, Emory University Director, Cardiac Catheterization

More information

Maria Angela S. Cruz-Anacleto, MD

Maria Angela S. Cruz-Anacleto, MD Maria Angela S. Cruz-Anacleto, MD 57/Female Menopausal Non-HTN, non-dm Hypothyroid (s/p RAI 1997) Levothyroxine 100 ug OD 5 Months PTA Chest discomfort Stress Echocardiography 5 Months PTA Chest discomfort

More information

Dyslipidemia Endothelial dysfunction Free radicals Immunologic

Dyslipidemia Endothelial dysfunction Free radicals Immunologic ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and

More information